Rethinking Medtech Innovation: Simple, Domestic Solutions that Cut Costs and Save Lives

During a time of economic turbulence, the healthcare system is under immense pressure. Rising costs, staffing shortages, and growing administrative burdens are pushing healthcare systems to their limits. Despite these challenges, expectations for better patient outcomes and more efficient operations haven’t let up.

This strain is especially intense in acute care settings where small errors can have serious consequences, with no room for inefficiency. In 2022 alone, over 1.25 million serious adverse drug events were reported globally, leading to an estimated 175,000 deaths. This is just one example that underscores the urgent need for practical innovations that reduce error without adding complexity or cost to the healthcare system.

At the same time, medical device manufacturers are facing new challenges and uncertainties as they respond to new tariffs and a rapidly shifting regulatory landscape. The path forward is not through overly complicated solutions with long regulatory timelines. It is through simpler, smarter tools designed with frontline clinicians in mind and manufactured close to home.

Acute Care Problem: Disconnected, Dangerous & Expensive

In high-acuity settings, intravenous (IV) line confusion and mismanagement represent one of the most persistent problems in acute care. Despite advances in medical device technology, many hospitals still rely on manual labeling and line tracing methods, leaving far too much room for error. This can lead to longer hospital stays while negatively impacting patient safety and the bottom line.

A 2016 Johns Hopkins study identified medical error as the third leading cause of death in the United States. Among these, infusion-related mistakes are a major contributor, especially in ICUs and emergency departments. Stakes are high, and clinicians are often forced to identify critical IV lines in poor lighting and high-stress environments. On average, ICU patients have eight infusion lines running simultaneously, making fast, accurate identification not only challenging but critical to patient safety.

Beyond the effects on patients and providers, medical errors can have a significant impact on organizations and the healthcare sector as a whole. On average, healthcare providers are paying $450,000 in avoidable direct ADE costs per year per 100 beds in the hospital. This is from direct costs, and does not factor in labor or patient harm liability suits. Industry-wide, infusion-related errors are estimated to add $2 billion annually to U.S. healthcare costs.

Innovating a Smart, Simple Solution

The most effective ideas in healthcare innovation don’t need to be complex. By shifting the focus toward simplicity, we open the door to fast, meaningful improvements that have positive impacts across the healthcare industry. One example is light-enabled IV-line tracing technology. By using light to visually confirm line-to-medication connections at the bedside, clinicians can gain clarity in seconds instead of minutes.

A peer-reviewed study from Wake Forest University School of Medicine, published in the Journal of Infusion Nursing, found that nurses working in dim conditions took significantly longer to trace IV lines, increasing the risk of error. Light-guided systems help to address this issue directly, reducing confusion and cognitive load.

Best of all, these solutions work with the tools hospitals already have. These innovative solutions work seamlessly with current workflow and systems, and they don’t require major training, infrastructure changes, or regulatory overhauls, as they’re built to integrate easily and deliver results immediately.

From Concept to Bedside: Scaling & U.S. Manufacturing

Scalability matters. The success of any medical device and medtech innovation depends on how well it fits into the existing clinical environment. Light-enabled IV tracing has proven its value through partnerships with both hospital systems and infusion pump manufacturers. Much of its success comes from its plug-and-play compatibility with existing EHRs and bedside tools, allowing hospitals to improve safety without disrupting workflows.

Seamless workflow integration is essential in high-pressure healthcare environments, where clinicians must juggle multiple tasks without added friction. Medical devices that align with existing protocols and infrastructure reduce training time, minimize resistance to adoption, and maintain operational efficiency. By eliminating the need for complex onboarding or disruptive system overhauls, truly integrated technologies can enhance patient safety and clinical performance without slowing teams down.

Producing this technology domestically adds another layer of value, especially given the shifts in the supply chain. Many of the leading light-enabled IV solutions are manufactured in the United States, which in turn shortens supply chains, ensures better quality control, and sidesteps many regulatory delays. In today’s healthcare landscape, where overseas manufacturing delays can halt progress, local production offers much-needed reliability.

Delivering Measurable Value

Clinical data demonstrates the value of these novel solutions. The aforementioned Wake Forest University School of Medicine study, which was conducted with experienced intensive care unit (ICU) nurses, found that light-enabled IV solutions were 24 percent faster in accessing the primary medication line injection port and 40 percent less mental tasking when compared to standard labeling practices.

In addition, a four-month study conducted at a major VA hospital in Houston found that smart, light-enabled IV systems reduced the time to medication port access by over 400 percent. Traditional methods took between 19 to 58 seconds, while the new system took just one to seven seconds.

The impact on hospital operations was immediate, with nurses reporting fewer medication-related delays and the hospital observing reduced overtime hours. These small changes drive big returns, on safety, on efficiency, and on margins.

What’s Next: Beyond IVs and Into Broader Applications

The approach of building smart, simple tools have positive implications far beyond infusion care. Similar technologies are now being explored in pump programming, outpatient and long-term care, and even dental settings. The goal is the same: support clinicians while improving outcomes for patients.

Future opportunities include integration with AI and predictive analytics, helping healthcare providers not only prevent errors but also anticipate them. The vision is a connected ecosystem of intuitive, interoperable tools that are affordable, reliable, and quick to adopt.

A Blueprint for Medtech Innovation

This model of simple design, domestic manufacturing, and seamless integration should serve as a blueprint for the next generation of medical device solutions. It is time to move away from unnecessarily complex solutions that demand years of development and steep training curves.

Instead, we should prioritize tools that are easy to scale, require minimal regulatory friction, and bring immediate value to the bedside. The most effective solutions don’t always look high-tech. Sometimes, they just look smart.

Advances in light-enabled IV products are just one example, but these solutions represent a shift in how we think about medtech innovation. As hospitals work to control costs, improve care, and reduce risk, the future belongs to tools that are intuitive, efficient, and manufactured with resilience in mind.

This is how healthcare improves, not just with big ideas, but with the right ones.

Rodney W. Schutt is the President & CEO of Orion Innovations, a healthcare technology platform company advancing smart, simple, and patented solutions that improve patient safety and enhance the bottom line. This includes the MedLite ID solution, which is an nine-time patented smart-lite product designed to simplify the current line-tracing process in acute care settings and reduce the chance of IV infusion-related errors leading to a wrong-route Adverse Drug Event (ADE).